# Advertised vs Billed GLP-1 Prices: Every Correction, by Type | This GLP Every corrected GLP-1 seller price, sorted by outcome: restated upward for a fee, a four-week cycle or a prepay rung, withdrawn entirely, or corrected in a field other than the price. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/research/glp1-advertised-vs-billed-corrections Updated: 2026-10-28 Published: 2026-09-16 [← Research](https://thisglp.com/research) Formats # Advertised vs Billed GLP-1 Prices: Every Correction, by Type Most corrections to a published GLP-1 price exist for one reason: the advertised figure is not the billed one. A few exist because no figure could be published at all. [This GLP Editorial Team](https://thisglp.com/about)September 20265 min readUpdated September 2026 What happened to 380 corrected price rows · 250 restated — the billed figure is higher · 95 withdrawn — no figure could be published · 35 corrected a field other than the price · Across 199 sellers. **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms). The single most common thing wrong with a GLP-1 price is that it is not the price. Across the sellers this desk has worked through, 199 carry at least one correction, over 380 separate price rows — and the largest group by far, 250 of them, exists because the figure a seller advertises is not the figure a buyer is billed. Before comparing anything on [a board](https://thisglp.com/best), it is worth knowing what kinds of gap keep appearing. ## Three different outcomes A correction is arithmetic on what a seller publishes, and it has three possible endings. The commonest, 250 rows or 66% of the corrected set, restates the figure upward: a mandatory membership added, a four-week cycle converted to a calendar month, a prepay rung separated from the monthly rate it was standing in for. The second, 95 rows, withdraws the price entirely. Those are sellers whose published figures could not be resolved into anything a buyer could be held to — two pages giving one number different meanings, a savings line printed where a price goes, a default carried by a shared template. Publishing any of those would have put a number on a board that nobody is charged. The third and smallest, 35 rows, leaves the price alone and corrects something else — a product recorded as an injection that is an oral, a compounded row that is actually brand. Those change what a figure describes without changing the figure. ## What this is not a rate of This counts corrections written, not sellers audited. A row enters the count when somebody read the seller, found the gap and did the arithmetic, so the denominator is the worked set rather than the 580 sellers on the roster. It would be easy and wrong to turn these into a percentage of the market. What it does establish is the shape of the problem. The gaps are not random errors — they cluster into a small number of repeated structures, and once a reader can recognize those structures they can check for them on any page, including sellers nobody has corrected yet. ## The four that keep recurring A billing cycle that is four weeks rather than a month, which adds a thirteenth charge a year — counted separately in [a month that is not a month](https://thisglp.com/research/glp1-four-week-billing-cycles). A required fee outside the medication price. A first-month or promotional figure printed where the standing rate belongs. And a prepay rung presented as though it were the monthly rate. All four are checkable before paying, and all four are invisible if you read only the number. The questions that surface them are in [the questions they leave open](https://thisglp.com/tools/questions-they-leave-open), and the broader census of what goes unpublished is in [what sellers will not tell you](https://thisglp.com/research/what-glp1-sellers-do-not-publish). Every figure above is computed from this site’s own correction records at the moment the page was built, most recently read October 2026. [Calibrate](https://thisglp.com/reviews/calibrate-health) makes another distinction explicit in its [pricing page](https://www.joincalibrate.com/pricing): program membership excludes lab tests and prescription medication and carries an initial commitment. The program price and an insured prescription copay are different expenses; neither should silently stand in for the other. ## Frequently asked How often is the advertised price wrong? This counts corrections written rather than sellers audited, so it is not a rate. What it shows is that the largest group of corrections by far exists because the advertised figure is not the billed one. Why would a price be withdrawn entirely? Because nothing publishable could be resolved — two pages giving one number different meanings, a savings line printed where a price goes, or a default carried by a shared template. What should I check on a seller's page? The billing interval, any required fee outside the medication, whether the figure is a first month or a promotion, and whether it belongs to a prepaid term rather than a month. ## Sources ## Where to get it ### Best GLP-1 injections Every injectable seller we can verify, with the price each one publishes and an honest read of what the trials measured. [Compare providers →](https://thisglp.com/best/compounded-semaglutide) ## More in Formats - [ Label-approved sites and semaglutide exposure · Abdomen · 2 in. from navel · similar · Thigh · under the skin · similar · Upper arm · under the skin · similar · Blood levels, not weight loss. No trial randomized people to a site. ### Where Should You Inject Ozempic? Abdomen, Thigh or Arm Gave the Same Exposure ](https://thisglp.com/research/where-should-you-inject-ozempic) - [ The labeled ladder — four weeks on every rung · 0.25 · wk 1–4 · 0.5 · wk 5–8 · 1 · wk 9–12 · 1.7 · wk 13–16 · 2.4 · wk 17+ · Milligrams weekly. No compounded product carries this label. ### Semaglutide Starting Dose: 0.25 mg, and What Compounding Changes ](https://thisglp.com/research/semaglutide-starting-dose) - [ Approved: weight management, US, April 2026 · Phase 3 in progress, not approved: · sleep apnea · hypertension · urinary incontinence · osteoarthritis pain · artery disease · A daily tablet, not a peptide, not an injection. ### Is There a GLP-1 Pill That Works? Two Tablets, Two Different Answers ](https://thisglp.com/research/does-the-glp1-pill-work-as-well-as-the-injection)